J A Katzenellenbogen - JoVE Visualize

Showing results (101-110 of 199) with videos related to

Pageof 20

Sort By:

Bioorganic & Medicinal Chemistry|February 24, 2001

Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptorS R Stauffer, Y Huang, C J Coletta, et al.

Journal of Medicinal Chemistry|June 9, 1995

Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding siteM Cushman, H M He, J A Katzenellenbogen, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998

Evidence that phospholipase A2 activity is required for Golgi complex and trans Golgi network membrane tubulationP de Figueiredo, D Drecktrah, J A Katzenellenbogen, et al.

Biochemistry|December 16, 1997

Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interactionK E Carlson, I Choi, A Gee, et al.

Bioconjugate Chemistry|September 1, 1991

Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapyJ P DiZio, R Fiaschi, A Davison, et al.

Cancer Research|October 1, 1983

New approach for visualizing estrogen receptors in target cells using inherently fluorescent ligands and image intensificationP M Martin, H P Magdelenat, B Benyahia, et al.

Journal of Medicinal Chemistry|August 16, 1996

Design, synthesis, and biological evaluation of ellipticine-estradiol conjugatesR Devraj, J F Barrett, J A Fernandez, et al.

Journal of Medicinal Chemistry|November 16, 2001

Salicylaldoxime moiety as a phenolic "A-Ring" substitute in estrogen receptor ligandsF Minutolo, S Bertini, C Papi, et al.

Journal of Medicinal Chemistry|July 8, 1999

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenesM J Meyers, J Sun, K E Carlson, et al.

Journal of Medicinal Chemistry|December 1, 1979

Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metaboliteT Tatee, K E Carlson, J A Katzenellenbogen, et al.

Pageof 20

Showing results (101-110 of 199) with videos related to

Sort By:

Pageof 20

Bioorganic & Medicinal Chemistry|February 24, 2001

Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptorS R Stauffer, Y Huang, C J Coletta, et al.

Journal of Medicinal Chemistry|June 9, 1995

Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding siteM Cushman, H M He, J A Katzenellenbogen, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998

Evidence that phospholipase A2 activity is required for Golgi complex and trans Golgi network membrane tubulationP de Figueiredo, D Drecktrah, J A Katzenellenbogen, et al.

Biochemistry|December 16, 1997

Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interactionK E Carlson, I Choi, A Gee, et al.

Bioconjugate Chemistry|September 1, 1991

Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapyJ P DiZio, R Fiaschi, A Davison, et al.

Cancer Research|October 1, 1983

New approach for visualizing estrogen receptors in target cells using inherently fluorescent ligands and image intensificationP M Martin, H P Magdelenat, B Benyahia, et al.

Journal of Medicinal Chemistry|August 16, 1996

Design, synthesis, and biological evaluation of ellipticine-estradiol conjugatesR Devraj, J F Barrett, J A Fernandez, et al.

Journal of Medicinal Chemistry|November 16, 2001

Salicylaldoxime moiety as a phenolic "A-Ring" substitute in estrogen receptor ligandsF Minutolo, S Bertini, C Papi, et al.

Journal of Medicinal Chemistry|July 8, 1999

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenesM J Meyers, J Sun, K E Carlson, et al.

Journal of Medicinal Chemistry|December 1, 1979

Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metaboliteT Tatee, K E Carlson, J A Katzenellenbogen, et al.

Pageof 20